Dr. Garon on the KEYNOTE-001 Study in NSCLC

Edward B. Garon, MD, MS, associate professor of medicine, David Geffer School of Medicine, University of California, Los Angeles, discusses the KEYNOTE-001 study, which examined the 5-year long-term overall survival in patients with non–small cell lung cancer treated with pembrolizumab. Website: https://www.onclive.com Twitter:   / onclive   Facebook:   / onclive   LinkedIn:   / onclive